Dearborn Partners’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $347K | Sell |
3,347
-322
| -9% | -$36.5K | 0.02% | 212 |
|
|
2025
Q4 | $370K | Sell |
3,669
-250
| -6% | -$27.1K | 0.02% | 206 |
|
|
2025
Q3 | $483K | Sell |
3,919
-103
| -3% | -$12.8K | 0.02% | 182 |
|
|
2025
Q2 | $483K | Sell |
4,022
-174
| -4% | -$23.2K | 0.02% | 181 |
|
|
2025
Q1 | $618K | Hold |
4,196
| – | – | 0.03% | 143 |
|
|
2024
Q4 | $681K | Buy |
4,196
+61
| +1% | +$9.98K | 0.03% | 141 |
|
|
2024
Q3 | $674K | Sell |
4,135
-212
| -5% | -$31.4K | 0.03% | 141 |
|
|
2024
Q2 | $593K | Sell |
4,347
-549
| -11% | -$76.2K | 0.03% | 150 |
|
|
2024
Q1 | $750K | Sell |
4,896
-888
| -15% | -$133K | 0.03% | 134 |
|
|
2023
Q4 | $825K | Sell |
5,784
-705
| -11% | -$94K | 0.03% | 128 |
|
|
2023
Q3 | $850K | Sell |
6,489
-1,449
| -18% | -$220K | 0.03% | 116 |
|
|
2023
Q2 | $1.26M | Sell |
7,938
-1,265
| -14% | -$204K | 0.05% | 95 |
|
|
2023
Q1 | $1.46M | Sell |
9,203
-2,604
| -22% | -$391K | 0.06% | 90 |
|
|
2022
Q4 | $1.66M | Buy |
11,807
+54
| +0.5% | +$7.66K | 0.07% | 91 |
|
|
2022
Q3 | $1.51M | Sell |
11,753
-1,257
| -10% | -$181K | 0.07% | 94 |
|
|
2022
Q2 | $1.83M | Sell |
13,010
-432
| -3% | -$61.7K | 0.08% | 84 |
|
|
2022
Q1 | $1.87M | Sell |
13,442
-173,530
| -93% | -$26.6M | 0.07% | 88 |
|
|
2021
Q4 | $32.6M | Sell |
186,972
-6,126
| -3% | -$1.02M | 1.18% | 41 |
|
|
2021
Q3 | $32M | Buy |
193,098
+1,407
| +0.7% | +$242K | 1.3% | 40 |
|
|
2021
Q2 | $34.5M | Buy |
191,691
+2,062
| +1% | +$376K | 1.39% | 37 |
|
|
2021
Q1 | $36.6M | Buy |
189,629
+174,401
| +1,145% | +$33.6M | 1.56% | 26 |
|
|
2020
Q4 | $3.08M | Buy |
15,228
+106
| +0.7% | +$21.9K | 0.14% | 72 |
|
|
2020
Q3 | $3.18M | Sell |
15,122
-62
| -0.4% | -$13.8K | 0.16% | 71 |
|
|
2020
Q2 | $3.33M | Sell |
15,184
-2
| -0% | -$400 | 0.18% | 69 |
|
|
2020
Q1 | $2.63M | Sell |
15,186
-2,325
| -13% | -$384K | 0.16% | 71 |
|
|
2019
Q4 | $2.69M | Buy |
17,511
+2,695
| +18% | +$403K | 0.14% | 72 |
|
|
2019
Q3 | $2.25M | Buy |
14,816
+2
| +0% | +$316 | 0.13% | 73 |
|
|
2019
Q2 | $2.27M | Buy |
14,814
+1,433
| +11% | +$219K | 0.14% | 73 |
|
|
2019
Q1 | $2.15M | Sell |
13,381
-350
| -3% | -$54.3K | 0.14% | 73 |
|
|
2018
Q4 | $2.12M | Buy |
13,731
+941
| +7% | +$147K | 0.16% | 73 |
|
|
2018
Q3 | $1.92M | Buy |
12,790
+3,721
| +41% | +$529K | 0.13% | 73 |
|
|
2018
Q2 | $1.23M | Buy |
9,069
+3,747
| +70% | +$463K | 0.1% | 78 |
|
|
2018
Q1 | $708K | Buy |
5,322
+330
| +7% | +$44.3K | 0.05% | 93 |
|
|
2017
Q4 | $743K | Hold |
4,992
| – | – | 0.05% | 91 |
|
|
2017
Q3 | $658K | Hold |
4,992
| – | – | 0.05% | 97 |
|
|
2017
Q2 | $665K | Hold |
4,992
| – | – | 0.05% | 100 |
|
|
2017
Q1 | $673K | Sell |
4,992
-63
| -1% | -$8.16K | 0.05% | 100 |
|
|
2016
Q4 | $607K | Sell |
5,055
-34
| -0.7% | -$4.01K | 0.05% | 100 |
|
|
2016
Q3 | $637K | Buy |
5,089
+50
| +1% | +$6.55K | 0.05% | 111 |
|
|
2016
Q2 | $697K | Hold |
5,039
| – | – | 0.06% | 108 |
|
|
2016
Q1 | $635K | Hold |
5,039
| – | – | 0.06% | 109 |
|
|
2015
Q4 | $639K | Buy |
5,039
+150
| +3% | +$18.6K | 0.06% | 139 |
|
|
2015
Q3 | $565K | Sell |
4,889
-275
| -5% | -$30.9K | 0.06% | 148 |
|
|
2015
Q2 | $537K | Sell |
5,164
-2,392
| -32% | -$258K | 0.05% | 155 |
|
|
2015
Q1 | $834K | Sell |
7,556
-188
| -2% | -$20.4K | 0.07% | 173 |
|
|
2014
Q4 | $807K | Buy |
7,744
+104
| +1% | +$10.4K | 0.07% | 179 |
|
|
2014
Q3 | $734K | Buy |
7,640
+4
| +0.1% | +$362 | 0.07% | 185 |
|
|
2014
Q2 | $698K | Buy |
7,636
+3
| +0% | +$269 | 0.07% | 187 |
|
|
2014
Q1 | $671K | Buy |
7,633
+3
| +0% | +$263 | 0.07% | 187 |
|
|
2013
Q4 | $707K | Buy |
7,630
+4
| +0.1% | +$360 | 0.08% | 182 |
|
|
2013
Q3 | $623K | Buy |
7,626
+3
| +0% | +$253 | 0.08% | 190 |
|
|
2013
Q2 | $634K | Buy |
+7,623
| New | +$656K | 0.09% | 185 |
|
Other funds holding CLX
VCM
VPM
DAM
Dearborn Partners's CLX Position: Q1 2026 in Review
Dearborn Partners reduced its Clorox (CLX) stake by 8.8% in Q1 2026, selling an estimated $36.5K and leaving 3,347 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #212.
Dearborn Partners first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q1 2021. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Dearborn Partners held 3,347 shares of Clorox worth $347K as of Q1 2026.
- Dearborn Partners sold 322 Clorox shares in Q1 2026, an estimated $36.5K.
- Clorox made up 0.02% of Dearborn Partners's portfolio in Q1 2026, its #212 holding.
- Dearborn Partners first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Dearborn Partners's Clorox position peaked at $36.6M in Q1 2021.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.